Literature DB >> 23804325

Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment.

Donna J Cross1, Yoshimi Anzai, Eric C Petrie, Nathalie Martin, Todd L Richards, Kenneth R Maravilla, Elaine R Peskind, Satoshi Minoshima.   

Abstract

UNLABELLED: Olfactory dysfunction is an early feature of Alzheimer disease. This study used multimodal imaging of PET and (18)F-FDG combined with diffusion tensor imaging (DTI) to investigate the association of fiber tract integrity in the olfactory tract with cortical glucose metabolism in subjects with mild cognitive impairment (MCI) and normal controls. We hypothesized that MCI subjects would show loss of olfactory tract integrity and may have altered associations with glucose metabolism.
METHODS: Subjects diagnosed with amnestic MCI (n = 12) and normal controls (n = 23) received standard brain (18)F-FDG PET and DTI with 32 gradient directions on a 3-T MR imaging scanner. Fractional anisotropy (FA) maps were generated. Voxelwise correlation analysis of olfactory tract FA values with (18)F-FDG PET images was performed.
RESULTS: Integrated analysis over all subjects indicated a positive correlation between white matter integrity in the olfactory tract and metabolic activity in olfactory processing structures, including the rostral prefrontal cortex, dorsomedial thalamus, hypothalamus, orbitofrontal cortex, and uncus, and in the superior temporal gyrus, insula, and anterior cingulate cortex. Subjects with MCI, compared with normal controls, showed differential associations of olfactory tract integrity with medial temporal lobe and posterior cortical structures.
CONCLUSION: These findings indicate that impairment of axonal integrity or neuronal loss may be linked to functional metabolic changes and that disease-specific neurodegeneration may affect this relationship. Multimodal imaging using (18)F-FDG PET and DTI may provide better insights into aging and neurodegenerative processes.

Entities:  

Keywords:  18F-FDG PET; Alzheimer’s disease; DTI; fiber tract integrity; glucose metabolism; olfactory tract

Mesh:

Substances:

Year:  2013        PMID: 23804325      PMCID: PMC3999919          DOI: 10.2967/jnumed.112.116558

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

1.  Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease.

Authors:  Christoph Scherfler; Michael F Schocke; Klaus Seppi; Regina Esterhammer; Christian Brenneis; Werner Jaschke; Gregor K Wenning; Werner Poewe
Journal:  Brain       Date:  2005-11-04       Impact factor: 13.501

Review 2.  Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes.

Authors:  P J Magistretti; L Pellerin
Journal:  Cereb Cortex       Date:  1996 Jan-Feb       Impact factor: 5.357

Review 3.  Early detection of Alzheimer's disease using neuroimaging.

Authors:  Lisa Mosconi; Miroslaw Brys; Lidia Glodzik-Sobanska; Susan De Santi; Henry Rusinek; Mony J de Leon
Journal:  Exp Gerontol       Date:  2006-07-12       Impact factor: 4.032

4.  Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

Authors:  J Attems; K A Jellinger
Journal:  Clin Neuropathol       Date:  2006 Nov-Dec       Impact factor: 1.368

5.  Posterior cingulate cortex in Alzheimer's disease.

Authors:  S Minoshima; N L Foster; D E Kuhl
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

Review 6.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

7.  Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.

Authors:  S Minoshima; D J Cross; N L Foster; T R Henry; D E Kuhl
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 8.  Olfactory dysfunction as a predictor of neurodegenerative disease.

Authors:  Mark W Albers; Matthias H Tabert; D P Devanand
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

9.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

10.  Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

Authors:  S Minoshima; R A Koeppe; K A Frey; D E Kuhl
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

View more
  18 in total

1.  Olfactory Function and Associated Clinical Correlates in Former National Football League Players.

Authors:  Michael L Alosco; Johnny Jarnagin; Yorghos Tripodis; Michael Platt; Brett Martin; Christine E Chaisson; Christine M Baugh; Nathan G Fritts; Robert C Cantu; Robert A Stern
Journal:  J Neurotrauma       Date:  2016-08-11       Impact factor: 5.269

2.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

Review 3.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

Review 4.  PET imaging of neural activity, β-amyloid, and tau in normal brain aging.

Authors:  Kai Zhang; Hiroshi Mizuma; Xiaohui Zhang; Kayo Takahashi; Chentao Jin; Fahuan Song; Yuanxue Gao; Yousuke Kanayama; Yuping Wu; Yuting Li; Lijuan Ma; Mei Tian; Hong Zhang; Yasuyoshi Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-05       Impact factor: 9.236

5.  Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.

Authors:  Matthew R Woodward; Michael G Dwyer; Niels Bergsland; Jesper Hagemeier; Robert Zivadinov; Ralph Hb Benedict; Kinga Szigeti
Journal:  Psychiatry Res Neuroimaging       Date:  2017-06-09       Impact factor: 2.376

6.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

Review 7.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

8.  Quantitative magnetic susceptibility assessed by 7T magnetic resonance imaging in Alzheimer's disease caused by streptozotocin administration.

Authors:  Sangwoo Kim; Youngjeon Lee; Chang-Yeop Jeon; Keunil Kim; Youngjae Jeon; Yeung Bae Jin; Sukhoon Oh; Chulhyun Lee
Journal:  Quant Imaging Med Surg       Date:  2020-03

9.  Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in Brain Regions Involved in Early Stages of Parkinson's Disease.

Authors:  Nan-Kuei Chen; Ying-Hui Chou; Mark Sundman; Patrick Hickey; Willard S Kasoff; Adam Bernstein; Theodore P Trouard; Tanya Lin; Steven Z Rapcsak; Scott J Sherman; Carol P Weingarten
Journal:  Brain Connect       Date:  2018-08

10.  Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).

Authors:  James M Hill; Christian Clement; Aileen I Pogue; Surjyadipta Bhattacharjee; Yuhai Zhao; Walter J Lukiw
Journal:  Front Aging Neurosci       Date:  2014-06-16       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.